See also this year's filing and all EDGAR filings for this company.
PDF Report 0001373707_2017_Tetraphase_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001373707, Tetraphase Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 150,457,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,054,000 |
| 3 | remainder_Assets | 199,000 |
| 4 | LiabilitiesCurrent | 11,495,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,785,401 |
| 9 | ResearchAndDevelopmentExpense | 66,655,555 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 7,358,358 |
| 12 | remainder_NetIncome | 185,005 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 151,710,000 |
| 1 | Liabilities | 11,495,000 |
| 2 | Expenses | 86,440,956 |
| 3 | Revenues | 7,358,358 |
| 4 | StockholdersEquity | 140,215,000 |
| 5 | NetIncome | -78,897,593 |
| 6 | ComprehensiveNetIncome | -78,897,593 |
| 7 | BaseVar | 128,594,660 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.78 |
| 9 | EconomicCapitalRatio | 3.54 |
Edgar->Model Mapping
Feature Distribution
Change over Time
